Format

Send to

Choose Destination
Am J Obstet Gynecol. 2012 Sep;207(3):174.e1-7. doi: 10.1016/j.ajog.2012.06.050. Epub 2012 Jun 29.

The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals.

Author information

1
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Abstract

OBJECTIVE:

We analyzed the content, quality, and accuracy of information provided on hospital web sites about robotic gynecologic surgery.

STUDY DESIGN:

An analysis of hospitals with more than 200 beds from a selection of states was performed. Hospital web sites were analyzed for the content and quality of data regarding robotic-assisted surgery.

RESULTS:

Among 432 hospitals, the web sites of 192 (44.4%) contained marketing for robotic gynecologic surgery. Stock images (64.1%) and text (24.0%) derived from the robot manufacturer were frequent. Although most sites reported improved perioperative outcomes, limitations of robotics including cost, complications, and operative time were discussed only 3.7%, 1.6%, and 3.7% of the time, respectively. Only 47.9% of the web sites described a comparison group.

CONCLUSION:

Marketing of robotic gynecologic surgery is widespread. Much of the content is not based on high-quality data, fails to present alternative procedures, and relies on stock text and images.

PMID:
22835493
DOI:
10.1016/j.ajog.2012.06.050
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center